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Caucasians (CEU)  
from NCBI 
database 
HH/CY, HH/YY 
 and HD/CY individuals 
(n.75) 
HD/CC, DD/CC 
individuals SF>400ng/mL) 
[n.191] 
HD/CC, DD/CC 
Individuals (SF<400ng/mL) 
[n.98] 
    
    
 c.-1010C>T /c.-582 A>G  Frequency (%) Frequency (%) [n] p* Frequency (%) [n] p* Frequency (%) [n] p* 
Allele C/A 83.6 78.7 [118] 
0.1857 
68.8 [263] 
0.00006 
78.1 [153] 
0.1374 
T/G 16.4 21.3 [32] 31.2 [119] 21.9 [43] 
Total 100.0 100.0 [150] 100.0 [382] 100.0 [196] 
Genotype CC/AA 69.0 62.7 [47] 
0.0146 
47.1 [90] 
<0.00001 
62.2 [61] 
0.0022   CT/AG 29.3 32.0 [24] 43.5 [83] 31.6 [31] 
  TT/GG 1.7 5.3 [4] 9.4 [18] 6.1[6] 
  Total 100.0 100.0 [75]   100.0 [191]   100.0 [98] 
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Hepcidin is a 25 amino-acid peptide hormone known to be a crucial regulator of iron homeostasis. It is able to decrease the absorption of dietary iron in the duodenum and the release of recycled iron 
from macrophage, as well as the export of the stored iron from hepatocytes1.  
It is known that the deficiency in hepcidin levels leads to the development of iron overload and that, in contrast, its overproduction causes iron deficiency/anemia2.  
Several mutations located in the hepcidin gene (HAMP) have already been associated to the development of iron overload or hereditary hemochromatosis (HH). Additionally, some HAMP promoter 
variants were described, however their functional consequences remain unclear. One of them is the polymorphism c.-582 A>G, recently described to be in association with an increased iron overload 
phenotype in beta-thalassemia major patients3, but that has no effect on the iron status in the healthy population4. Also, functional assays have revealed that hepcidin expression becomes slightly 
reduced under the promoter G variant when transactivated by the upstream stimulatory factors 1 and 2 (USF1/USF2) in HepG2 cells5.   
The aims of this study were to determine: i) the frequency of the c.-582 A>G HAMP polymorphism in patients presenting the common HFE mutations (H63D and/or C282Y); ii) if it modulates iron 
overload in these patients and, iii) which are the upstream stimuli that are impaired by the polymorphism.  
→ 364 individuals with mutations in the HFE gene were screened for the 2.7-kb HAMP promoter variants 
        (i) 75 individuals carrying one or more C282Y alleles  (HH/CY, HH/YY or HD/CY) with serum ferritin (SF) 
higher than 400 ng/mL 
        (ii) 191 individuals homozygous or heterozygous for the H63D allele with SF higher than 400 ng/mL 
        (iii) 98 individuals homozygous or heterozygous for the H63D allele with SF lower than 400 ng/mL 
→ The 1.5-kb HAMP promoter sequence was cloned into the pGL2-enhancer vector and site-directed 
mutagenesis performed to obtain the polymorphic construct  
→ Huh-7 hepatoma cells were seeded in 35-mm plates, and the pGL2-enhancer constructions co-transfected 
along with pGL4.70 vector. Three hours post-transfection cells were submitted to different stimuli: (i) 20µM 
holo-transferrin, (ii) 4-6µM ferric citrate, (iii) 20ng/mL interleukin-6, (iv) 200µM cobalt chloride and (v) GDF15 
at physiological and pathological concentrations (500 and 150000pg/mL, respectively). Finally cells were 
harvested and luminescence assays performed 
HAMP promoter variants screening 
c.-582 A>G 
c.-1010 C>T 
→ The TG haplotype frequency (31.2%) observed in the group of individuals presenting one or 
two H63D alleles (HD/CC and DD/CC individuals) with high SF is much higher than the one 
observed in the CEU population (16.4%), while no significant difference was observed in the 
individuals carrying at least one C282Y allele (21.3%) or in HD/CC and DD/CC individuals with 
normal SF 
 
→ We have found differences in the genotype distribution in all the groups of analysed 
individuals. However it showed to be highly significant (p<0,00001) between the genotype 
distribution in HD/CC, DD/CC individuals with high SF when compared to the control 
population. Genotype appear to be biased by a high frequency of TT/GG and CT/AG individuals 
(9.4 and 43.5%, respectively) and a lower frequency in CC/AA individuals (47.1%) 
 
→ Interestingly, we observed that TG haplotype distribution (31.2%) in the HD/CC and DD/CC 
individuals with high SF is significantly higher than the one observed in HD/CC and DD/CC 
individuals with normal SF (p= 0.0196) 
 
•p-values were obtained by the Chi-square test 
•SF - Serum Ferritin 
Luminescence assays 
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Holo-transferrin and ferric citrate 
0,00 
0,40 
0,80 
1,20 
1,60 
2,00 
F
ir
e
fl
y
 l
u
ci
fe
ra
se
  
a
ct
iv
it
y
 n
o
rm
a
liz
e
d
  
to
 R
e
n
ill
a
 l
u
ci
fe
ra
se
 a
ct
iv
it
y
 
Interleukin-6 and cobalt chloride  
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Growth differentiation factor-15 
→ Two polymorphisms were found in the 
proximal region of the HAMP promoter, the 
c.-582 A>G and c.-1010 C>T 
 
→ These polymorphisms appear to be in 
linkage desequilibrium in our sample  
→ Both holo-transferrin and ferric 
citrate stimuli partially inhibit the 1.5kb-
HAMP promoter activity 
→ IL-6 is able to increase the promoter 
activity, while cobalt chloride, mimicking 
hypoxia, represses it 
→ GDF-15 stimulus seems not to affect the 
HAMP promoter activity neither at 
physiological nor pathological (beta-
thalassemia) concentrations 
Partially funded by FCT: Programa de Financiamento Plurianual do CIGMH; SFRH/BD/60718/2009 
In our study sample, the c.-582 A>G HAMP promoter polymorphism seems to be in linkage disequilibrium with the c.-1010 C>T HAMP polymorphism.   
In individuals that present H63D or C282Y mutations in HFE gene, the CT/AG and TT/GG genotypes are significantly more frequent than in the control caucasian population (NCBI database). 
However, when analysing the allele frequencies we only found significant differences in the group of individuals that have SF higher than 400ng/mL along with one or two H63D alleles (HD/CC and 
DD/CC individuals). We also observe that the allele frequency is also significantly different when comparing individuals having the same HD/CC or DD/CC background, but with different SF levels 
(higher polymorphism frequency found in individuals with SF levels higher than 400ng/mL). 
In silico studies show that both polymorphisms can disrupt highly predictable transcription factor binding sites, such as USF2 and TATA.  We tried to find which stimuli are impaired by these 
variants, however after performing luminescence assays we have found that neither holo-Tf, ferric citrate, IL-6, hypoxia nor GDF-15 seem to be the stimuli that become unable to trigger the HAMP 
promoter activity. 
In conclusion, c.-1010 C>T and c.-582 A>G polymorphisms seem to be a risk factor to iron overload development in individuals that by their H63D or C282Y background are already prone to develop 
this phenotype. 
No differences in the luciferase activity were 
observed in the polymorphic promoter when 
compared to the normal under the different 
analysed stimuli 
